Clinical trial
Efficacy & Safety of Pharmacokinetically-Driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis- A Double-Blind Placebo Controlled Clinical Trial
NCT05538208 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy & Safety of Pharmacokinetically-Driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis- A Double-Blind Placebo Controlled Clinical Trial
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- June 7, 2024
- Completion date
- January 31, 2027
- Enrollment
- 105 (estimated)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.